Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Patients With Crohn's Disease.

• Status: RECRUITING
• Trial end date: 2026-08-14

Summary

The purpose of this study is to measure the changes in intestinal uptake of radioligand \[11C\]AZ14132516 following multiple doses of AZD7798 in participants with Crohn's disease.

• Phase: PHASE1

Details

• Lead Sponsor: AstraZeneca
• Treatments: Drug Evaluation; Radioligand Assay